Atopic Dermatitis Clinical Trials in Arlington, Texas

3 studies are recruiting for atopic dermatitis in Arlington, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

    This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

    Stage
    Phase 2
    Ages
    18 to 100
    Site
    Novartis Investigative Site, Arlington, Texas
    Locations
    105 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT06947993 on ClinicalTrials.gov

  2. A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

    Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study compares upadacitinib to dupil…

    Stage
    Phase 3
    Ages
    2 to 11
    Site
    Arlington Research Center, Inc /ID# 266330, Arlington, Texas
    Locations
    150 in total
    Run by
    AbbVie

    See if you can join NCT06461897 on ClinicalTrials.gov

  3. A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

    Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy an…

    Stage
    Phase 3
    Ages
    18 to 63
    Site
    Arlington Research Center, Inc /ID# 263665, Arlington, Texas
    Locations
    128 in total
    Run by
    AbbVie

    See if you can join NCT06389136 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.